Pure Global
NCT06228170

Efficacy of Stellate Ganglion Block in Traumatic Brain Injury Patients

A Randomized Controlled Study to Explore the Efficacy of Stellate Ganglion Block in Traumatic Brain Injury Patients
Zeng Changhao·ClinicalTrials.gov·behavioralWithdrawn
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Traumatic Brain Injury
Drug/Device/Intervention
Rehabilitation therapy
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Zeng Changhao
Funder
People's Hospital of Zhengzhou University
Location
Zhengzhou, China
Timeline & enrollment
Phase
N/A
Start date
Jan 30, 2024
End date
May 30, 2024
Enrollment
0 participants
Primary outcome

Penetration-Aspiration Scale

Summary

The goal of this or clinical trial is to explore efficacy of stellate ganglion block on
 dysphagia and activities of daily living in Traumatic Brain Injury Patients. The main
 question it aims to answer are:
 
 Can stellate ganglion block improve the dysphagia and activities of daily living in Traumatic
 Brain Injury Patients.
 
 Traumatic Brain Injury Patients will be divided into the the control group and observation
 group evenly. All the patients were provided with routine therapy, while the patients in the
 observation group were given stellate ganglion block. The swallowing function, and activities
 of daily living of the two groups of patients before and after treatment were evaluated.

ICD-10 classifications
Diffuse brain injuryIntracranial injuryFocal brain injuryIntracranial injury, unspecifiedOther intracranial injuries
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06228170
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06228170 through Pure Global AI's free database. This phase not specified trial is sponsored by Zeng Changhao and is currently Withdrawn. The study focuses on Traumatic Brain Injury. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.